The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
Mittendorf
Robert
R
Roizen
Nancy J
NJ
Pryde
Peter G
PG
D002547:Cerebral Palsy / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature; D011247:Pregnancy; D015149:Tocolytic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D018696:Neuroprotective Agents; D015149:Tocolytic Agents; D008278:Magnesium Sulfate